Copertina

Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Lindsay M. Clarke, Jessica R. Allegretti
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
di: Camille Lupianez‐Merly, et al.
Pubblicazione: (2024)

Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series
di: Rahul S. Dalal, et al.
Pubblicazione: (2025)

Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Authors' Reply
di: Sara Ellegaard Paaske, et al.
Pubblicazione: (2026)

Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
di: Nurulamin M. Noor, et al.
Pubblicazione: (2024)

Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey
di: Nicolas Benech, et al.
Pubblicazione: (2024)

Improving Clinical Outcomes of Encapsulated Faecal Microbiota Transplantation for Clostridioides difficile Infection Through Empirical Donor Selection and Optimised Dosing: A Quality Improvement Study
di: Sara Ellegaard Paaske, et al.
Pubblicazione: (2025)

Review article: Diagnosis and management of laryngopharyngeal reflux
di: Amanda J. Krause, et al.
Pubblicazione: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
di: Peter R. Gibson, et al.
Pubblicazione: (2024)

Review article: Recommendations for detection, assessment and management of suspected drug‐induced liver injury during clinical trials in oncology patients
di: Anna Fettiplace, et al.
Pubblicazione: (2024)

Review article: advances in the diagnosis and management of anorectal motility disorders
di: Dariush Shahsavari, et al.
Pubblicazione: (2024)

Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
di: Danielle Adebayo, et al.
Pubblicazione: (2024)

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors
di: Matthew J. Townsend, et al.
Pubblicazione: (2024)

Review article: Oesophageal disorders in chronic liver disease
di: Francisco Idalsoaga, et al.
Pubblicazione: (2024)

Review article: Prevention of inflammatory bowel disease—The path forward
di: Sérgio Bronze, et al.
Pubblicazione: (2024)

Review article: Evaluation and care of the critically ill patient with cirrhosis
di: Iva Kosuta, et al.
Pubblicazione: (2024)

Review article: Current status and future directions of ingestible electronic devices in gastroenterology
di: Phoebe A. Thwaites, et al.
Pubblicazione: (2024)

Review article: Telecare in gastroenterology—Within the COVID‐19 pandemic and beyond
di: Fatima Hakak, et al.
Pubblicazione: (2024)

Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission
di: Arta Aliu, et al.
Pubblicazione: (2024)

Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
di: Thanaboon Chaemsupaphan, et al.
Pubblicazione: (2024)

Review article: Faecal biomarkers for assessing small intestinal damage in coeliac disease and environmental enteropathy
di: Laura Kivelä, et al.
Pubblicazione: (2024)

Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
di: Christy Riggott, et al.
Pubblicazione: (2024)

Review article: Seeing Is Believing–The Eosinophilic Oesophagitis Endoscopic Reference Score Can Serve as a Valuable Clinical Trial Endpoint in Eosinophilic Oesophagitis
di: Ikuo Hirano, et al.
Pubblicazione: (2025)

Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
di: Pojsakorn Danpanichkul, et al.
Pubblicazione: (2024)

Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
di: Pegah Golabi, et al.
Pubblicazione: (2024)

Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States
di: Richie Manikat, et al.
Pubblicazione: (2024)

Editorial: Updated epidemiology of steatotic liver disease in people withHIVin the United States—Authors' reply
di: Samer Gawrieh, et al.
Pubblicazione: (2024)

Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers—A Conundrum That Continues. Authors' Reply
di: Jessica A. Fitzpatrick, et al.
Pubblicazione: (2025)

Editorial: Defining corticosteroid use in clinical trials
di: J. Siffledeen
Pubblicazione: (2024)

Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial
di: Elliot B. Tapper, et al.
Pubblicazione: (2024)

Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease
di: Jannis Kountouras, et al.
Pubblicazione: (2024)

Outcomes of patients with alcohol‐associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium
di: Ann T. Ma, et al.
Pubblicazione: (2024)

Functional Constipation: Pathophysiology, evaluation, and management
di: Alexandra Kilgore, et al.
Pubblicazione: (2024)

Letter: Dietary emulsifiers and intestinal health—The beginning of an evolving story: Authors’ reply
di: Jessica A. Fitzpatrick, et al.
Pubblicazione: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply
di: Jessica A. Fitzpatrick, et al.
Pubblicazione: (2024)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—An emulated clinical trial
di: Mingsi Zhang, et al.
Pubblicazione: (2024)

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease
di: Nabil Noureddin, et al.
Pubblicazione: (2024)

Long‐term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
di: María Chaparro, et al.
Pubblicazione: (2024)

Editorial: The future of managing drug induced liver injury
di: Amanda Nicoll
Pubblicazione: (2024)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—an emulated clinical trial. Authors' reply
di: Elliot B. Tapper, et al.
Pubblicazione: (2024)

Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
di: Lisa Sandmann, et al.
Pubblicazione: (2024)